Speaker: Olivia Peralta, MD IM Resident, PGY-3 No Disclosures Objectives: -Pathophysiology of anaerobic and aerobic metabolism - Prevalence of Lactic Acidosis and Prognostic Indications -Types of Lactic Acidosis -Role of Thiamine in the setting of persistent Lactic Acidosis -Approach to and management of Lactic Acidosis ..read more

Speaker: Judy Mikhail, PhD, MBA, RN Editor-in-Chief, Journal of Trauma Nursing Program Manager, Michigan Trauma Quality Improvement Program University of Michigan Disclosures: None Objectives: • Identify the outline of a scholarly article, including how to formulate a compelling introduction, effectively discuss methods, present results, and conclude with a powerful discussion that can stimulate further research. • Employ strategies for clarity, conciseness and precision in one’s writing, including identifying and rectifying common pitfalls such as passive voice, excessive jargon or verbosity ..read more

Speaker: Brian Schuler, MD System Director, Clinical Cardiac Electrophysiology WellSpan Health, York, PA Disclosures: Speaker and Consultant: Canon Medical, USA Speaker, Consultant, and Medical Advisory Board: Boston Scientific Objectives: •Demonstrate the utility of the CT-Angio Suite for EP/cath procedures. •Review data strongly suggesting CT-guided LAAO is the gold standard of PDL prevention. •Review data demonstrating CT-Angio Suite is a fee-for-service and value-based care champion ..read more

Dr. Bedri Yusuf, Andrei Boyarshinov, Steve Kelly, Kassandra Lawson, Dr. Hellen Ransom, and Dr. Janeane Walker Steve Kelly, Compliance Kassandra Lawson, Associate Counsel, Legal Department Hellen Ransom, PhD, Clinical Ethicist Bedri Yusuf, MD, Chief Physician Executive Janeane Walker, PhD, RN, Director Faculty Development and Educational Outcomes ..read more

Speaker: Ruben Ruiz Vega, MD IM Resident, PGY-3 No Disclosures Objectives: • Understand the concept of ctDNA by defining what it is and learning its relevance in cancer research and diagnostics. • Grasp the clinical applications of ctDNA by discovering how ctDNA is utilized in cancer diagnosis, prognosis, treatment monitoring and early detection, and the potential impact on patient care. • Identify the challenges and limitations of working with ctDNA, including issues related to sensitivity and specificity. • Explore ctDNA’s role in personalized medicine and its potential for other medical app ..read more

..read more

Learning Objectives: 1. To critically review and understand the current data and studies regarding metformin as an 'anti-aging' drug through various pathways 2. To help guide future practice and therapy based on current evidence regarding metformin and other longevity medications The speaker has no disclosures ..read more

Title: Comprehensive Care of the Cardiomyopathy Patient: From Pillars that Sustain to Buttresses that Assist Presented by: J. Eduardo Rame, MD, MPhil, FAHA, FESC Director of Advanced Heart Failure & Cardiac Transplant Thomas Jefferson University Division of Cardiology, Philadelphia, PA Financial Disclosure: Co-Primary Investigator ReSTAGE HF (Thoratec, now Abbott, Inc) Primary Investigagor ADVANCE and ENDURANCE (HeartWare, now Medtronic Inc) National PI: SoPRANO (Macitentan post LVAD, Jannsen) Objectives: 1. To describe the different adaptations of human heart failure 2. To describe the po ..read more

IM Grand Rounds: Delirium in Hospitalized Older Adults Speaker: Akshay Kumar, MD PGY-3 IM Resident No Disclosures Objectives: -Identify what constitutes delirium in an institutionalized older adults. -How to appropriately assess and manage delirium in acute setting as per latest guidelines. -Measures healthcare provider should take to prevent onset of delirium in hospitalized setting ..read more

Enduring CME will expire on 6/26/2025 Speaker: Jeffrey Popma, MD Vice President and Chief Medical Officer, Structural Heart, Coronary and Renal Denervation, Medtronic Professor of Medicine, Emeritus, Harvard Medical School, Boston No disclosures Objectives: • Review the critical value of clinician investigation in the discovery of medical devices to serve unmet patient needs. • Discuss the risks and benefits of transcatheter aortic valve replacement in patients with severe aortic stenosis. • Outline the clinical outcomes associated with transcatheter treatment of patients with symptomatic, sev ..read more